NCT00587132View on ClinicalTrials.gov

Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Pancreatic Cancer
Interventions
DRUG

Synthetic Human Secretin

0.2mcg/kg one time dose.

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic

Collaborators (1)

ChiRhoClin, Inc.
All Listed Sponsors
collaborator

ChiRhoClin, Inc.

INDUSTRY

lead

Mayo Clinic

OTHER